Adam Maeder
Stock Analyst at Piper Sandler
(3.75)
# 666
Out of 4,870 analysts
88
Total ratings
50%
Success rate
8.84%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Neutral | $3.5 → $4 | $4.34 | -7.83% | 1 | Jun 18, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $80 → $83 | $75.32 | +10.20% | 15 | May 13, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $2.52 | +58.73% | 4 | May 12, 2025 | |
| TCMD Tactile Systems Technology | Downgrades: Neutral | $25 → $14 | $10.18 | +37.52% | 3 | May 6, 2025 | |
| RMD ResMed | Maintains: Neutral | $260 → $248 | $254.52 | -2.56% | 3 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $670 → $575 | $515.09 | +11.63% | 19 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Reiterates: Overweight | $133 → $145 | $133.26 | +8.81% | 3 | Apr 17, 2025 | |
| RXST RxSight | Initiates: Neutral | $18 | $13.54 | +32.94% | 1 | Apr 15, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $11 → $8.5 | $7.85 | +8.28% | 7 | Mar 18, 2025 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $260 → $233 | $129.99 | +79.24% | 14 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $10.64 | +97.37% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $3.43 | +133.24% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $7.83 | +155.43% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.11 | +136.97% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $2.39 | +653.14% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $45.57 | +117.25% | 3 | May 5, 2022 |
Sight Sciences
Jun 18, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $4.34
Upside: -7.83%
Edwards Lifesciences
May 13, 2025
Maintains: Overweight
Price Target: $80 → $83
Current: $75.32
Upside: +10.20%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $2.52
Upside: +58.73%
Tactile Systems Technology
May 6, 2025
Downgrades: Neutral
Price Target: $25 → $14
Current: $10.18
Upside: +37.52%
ResMed
Apr 24, 2025
Maintains: Neutral
Price Target: $260 → $248
Current: $254.52
Upside: -2.56%
Intuitive Surgical
Apr 23, 2025
Maintains: Overweight
Price Target: $670 → $575
Current: $515.09
Upside: +11.63%
Abbott Laboratories
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $133.26
Upside: +8.81%
RxSight
Apr 15, 2025
Initiates: Neutral
Price Target: $18
Current: $13.54
Upside: +32.94%
Vicarious Surgical
Mar 18, 2025
Maintains: Neutral
Price Target: $11 → $8.5
Current: $7.85
Upside: +8.28%
Inspire Medical Systems
Feb 10, 2025
Maintains: Overweight
Price Target: $260 → $233
Current: $129.99
Upside: +79.24%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $10.64
Upside: +97.37%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $3.43
Upside: +133.24%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $7.83
Upside: +155.43%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.11
Upside: +136.97%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $2.39
Upside: +653.14%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $45.57
Upside: +117.25%